Mason Street Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-197,530
Closed -$7.1M 188
2020
Q4
$7.1M Sell
197,530
-3,412
-2% -$123K 0.12% 152
2020
Q3
$7.68M Sell
200,942
-3,024
-1% -$117K 0.15% 120
2020
Q2
$7.16M Buy
203,966
+5,100
+3% +$184K 0.14% 125
2020
Q1
$6.49M Hold
198,866
0.15% 124
2019
Q4
$8.99M Buy
198,866
+413
+0.2% +$17.3K 0.17% 103
2019
Q3
$8.07M Buy
198,453
+122
+0.1% +$5.17K 0.17% 107
2019
Q2
$8.52M Buy
198,331
+605
+0.3% +$23.3K 0.18% 100
2019
Q1
$7.59M Buy
197,726
+2,631
+1% +$100K 0.15% 118
2018
Q4
$6.89M Buy
195,095
+686
+0.4% +$24.9K 0.17% 106
2018
Q3
$7.49M Buy
194,409
+818
+0.4% +$28.6K 0.15% 118
2018
Q2
$6.33M Buy
193,591
+2,069
+1% +$62.4K 0.14% 127
2018
Q1
$5.23M Buy
191,522
+247
+0.1% +$6.71K 0.12% 160
2017
Q4
$4.74M Buy
191,275
+798
+0.4% +$22K 0.11% 185
2017
Q3
$5.56M Buy
190,477
+419
+0.2% +$11.6K 0.13% 137
2017
Q2
$5.27M Buy
190,058
+1,634
+0.9% +$43.4K 0.13% 137
2017
Q1
$4.69M Buy
188,424
+2,154
+1% +$52.4K 0.12% 152
2016
Q4
$4.03M Buy
186,270
+2,189
+1% +$47.8K 0.11% 182
2016
Q3
$4.38M Buy
184,081
+1,319
+0.7% +$31.5K 0.12% 158
2016
Q2
$4.27M Buy
182,762
+3,160
+2% +$68.4K 0.12% 152
2016
Q1
$3.38M Buy
179,602
+3,867
+2% +$67.9K 0.1% 198
2015
Q4
$3.24M Buy
175,735
+1,846
+1% +$33.1K 0.1% 209
2015
Q3
$2.85M Buy
173,889
+1,258
+0.7% +$21.5K 0.1% 233
2015
Q2
$3.06M Buy
172,631
+1,282
+0.7% +$22.9K 0.09% 230
2015
Q1
$3.04M Sell
171,349
-776,304
-82% -$12.3M 0.09% 237
2014
Q4
$12.6M Buy
947,653
+535,097
+130% +$6.84M 0.09% 276
2014
Q3
$4.87M Buy
412,556
+4,232
+1% +$53.3K 0.04% 525
2014
Q2
$5.21M Buy
408,324
+20,310
+5% +$264K 0.04% 510
2014
Q1
$5.25M Sell
388,014
-5,350
-1% -$70.2K 0.04% 499
2013
Q4
$4.73M Buy
393,364
+139,394
+55% +$1.65M 0.04% 540
2013
Q3
$2.98M Sell
253,970
-30,232
-11% -$327K 0.03% 524
2013
Q2
$2.63M Buy
+284,202
New +$2.41M 0.03% 589

Other funds holding BSX